Emerging role of alpha-lipoic acid in the prevention and treatment of bone loss

Joseph L. Roberts, Régis Moreau

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Osteoporosis is a chronic disease associated with decreased bone density that afflicts millions of people worldwide. Current pharmacological treatments are limited, costly, and linked to several negative side effects. These factors are driving current interest in the clinical use of naturally occurring bioactive compounds to mitigate bone loss. Alpha-lipoic acid, a potent antioxidant and essential member of mitochondrial dehydrogenases, has shown considerable promise as an antiosteoclastogenic agent due to its potent reactive oxygen species-scavenging capabilities along with a proven clinical safety record. Collectively, current data indicate that alpha-lipoic acid protects from bone loss via a 2-pronged mechanism involving inhibition of osteoclastogenic reactive oxygen species generation and upregulation of redox gene expression.

Original languageEnglish (US)
Pages (from-to)116-125
Number of pages10
JournalNutrition Reviews
Volume73
Issue number2
DOIs
StatePublished - Jan 1 2015

Fingerprint

Thioctic Acid
Reactive Oxygen Species
Bone and Bones
Bone Density
Osteoporosis
Oxidation-Reduction
Oxidoreductases
Chronic Disease
Up-Regulation
Antioxidants
Pharmacology
Safety
Gene Expression

Keywords

  • Alpha-lipoic acid
  • Bone loss
  • NF-κB
  • Osteoblast
  • Osteoclast
  • Osteoporosis
  • Oxidative stress
  • RANKL

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Emerging role of alpha-lipoic acid in the prevention and treatment of bone loss. / Roberts, Joseph L.; Moreau, Régis.

In: Nutrition Reviews, Vol. 73, No. 2, 01.01.2015, p. 116-125.

Research output: Contribution to journalArticle

@article{1415f0c2ef65434895c529abf2526bd0,
title = "Emerging role of alpha-lipoic acid in the prevention and treatment of bone loss",
abstract = "Osteoporosis is a chronic disease associated with decreased bone density that afflicts millions of people worldwide. Current pharmacological treatments are limited, costly, and linked to several negative side effects. These factors are driving current interest in the clinical use of naturally occurring bioactive compounds to mitigate bone loss. Alpha-lipoic acid, a potent antioxidant and essential member of mitochondrial dehydrogenases, has shown considerable promise as an antiosteoclastogenic agent due to its potent reactive oxygen species-scavenging capabilities along with a proven clinical safety record. Collectively, current data indicate that alpha-lipoic acid protects from bone loss via a 2-pronged mechanism involving inhibition of osteoclastogenic reactive oxygen species generation and upregulation of redox gene expression.",
keywords = "Alpha-lipoic acid, Bone loss, NF-κB, Osteoblast, Osteoclast, Osteoporosis, Oxidative stress, RANKL",
author = "Roberts, {Joseph L.} and R{\'e}gis Moreau",
year = "2015",
month = "1",
day = "1",
doi = "10.1093/nutrit/nuu005",
language = "English (US)",
volume = "73",
pages = "116--125",
journal = "Nutrition Reviews",
issn = "0029-6643",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Emerging role of alpha-lipoic acid in the prevention and treatment of bone loss

AU - Roberts, Joseph L.

AU - Moreau, Régis

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Osteoporosis is a chronic disease associated with decreased bone density that afflicts millions of people worldwide. Current pharmacological treatments are limited, costly, and linked to several negative side effects. These factors are driving current interest in the clinical use of naturally occurring bioactive compounds to mitigate bone loss. Alpha-lipoic acid, a potent antioxidant and essential member of mitochondrial dehydrogenases, has shown considerable promise as an antiosteoclastogenic agent due to its potent reactive oxygen species-scavenging capabilities along with a proven clinical safety record. Collectively, current data indicate that alpha-lipoic acid protects from bone loss via a 2-pronged mechanism involving inhibition of osteoclastogenic reactive oxygen species generation and upregulation of redox gene expression.

AB - Osteoporosis is a chronic disease associated with decreased bone density that afflicts millions of people worldwide. Current pharmacological treatments are limited, costly, and linked to several negative side effects. These factors are driving current interest in the clinical use of naturally occurring bioactive compounds to mitigate bone loss. Alpha-lipoic acid, a potent antioxidant and essential member of mitochondrial dehydrogenases, has shown considerable promise as an antiosteoclastogenic agent due to its potent reactive oxygen species-scavenging capabilities along with a proven clinical safety record. Collectively, current data indicate that alpha-lipoic acid protects from bone loss via a 2-pronged mechanism involving inhibition of osteoclastogenic reactive oxygen species generation and upregulation of redox gene expression.

KW - Alpha-lipoic acid

KW - Bone loss

KW - NF-κB

KW - Osteoblast

KW - Osteoclast

KW - Osteoporosis

KW - Oxidative stress

KW - RANKL

UR - http://www.scopus.com/inward/record.url?scp=84949185717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949185717&partnerID=8YFLogxK

U2 - 10.1093/nutrit/nuu005

DO - 10.1093/nutrit/nuu005

M3 - Article

C2 - 26024498

AN - SCOPUS:84949185717

VL - 73

SP - 116

EP - 125

JO - Nutrition Reviews

JF - Nutrition Reviews

SN - 0029-6643

IS - 2

ER -